Duchenne Muscular Dystrophy
Ifetroban for Treating DMD-Associated Cardiomyopathy
Feb 12, 2020 at 10:06 am by Staff
Cumberland Pharmaceuticals Gears up for Phase II Clinical Trial
Last fall, the U.S. Food and Drug Administration (FDA) announced $15 million in grant funding in support of 12.... Read More
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
Feb 10, 2017 at 08:10 am by Staff
On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dyst.... Read More